000 | 01391 a2200397 4500 | ||
---|---|---|---|
005 | 20250514061040.0 | ||
264 | 0 | _c20030416 | |
008 | 200304s 0 0 eng d | ||
022 | _a1527-9995 | ||
024 | 7 |
_a10.1016/s0090-4295(02)02268-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFreedland, Stephen J | |
245 | 0 | 0 |
_aDefining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen. _h[electronic resource] |
260 |
_bUrology _cFeb 2003 |
||
300 |
_a365-9 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLymph Node Excision _xmethods |
650 | 0 | 4 |
_aLymph Nodes _xpathology |
650 | 0 | 4 | _aLymphatic Metastasis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xblood |
650 | 0 | 4 |
_aProstate _xpathology |
650 | 0 | 4 |
_aProstate-Specific Antigen _xblood |
650 | 0 | 4 |
_aProstatectomy _xmethods |
650 | 0 | 4 |
_aProstatic Neoplasms _xblood |
650 | 0 | 4 | _aSurvival Analysis |
700 | 1 | _aSutter, Mark E | |
700 | 1 | _aDorey, Frederick | |
700 | 1 | _aAronson, William J | |
773 | 0 |
_tUrology _gvol. 61 _gno. 2 _gp. 365-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0090-4295(02)02268-9 _zAvailable from publisher's website |
999 |
_c12394770 _d12394770 |